Laser photocoagulation for upper gastrointestinal bleeding: The American experience

D. Fleischer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Laser use in the United States for the treatment of gastrointestinal disease in general, and for upper GI bleeding in particular has grown exponentially. In 1979, only 3 American medical centers were using lasers for the therapy of UGI bleeding. Today, lasers are employed in more than 200 centers. Recently, the Food and Drug Administration, which regulates its use, has ruled that it is safe and effective, and therefore is no longer considered to be an investigational device. Most commonly it is used to treat discrete lesions such as ulcers, but it has been employed for other lesions, including varices. A recent American randomized controlled trial assessing its efficacy in acute esophageal variceal bleeding, found it to be effective for initial hemostasis; however, rebleeding was common. A key question is whether or not the laser is superior to other less costly and more portable modalities for treating acute UGI bleeding. One U.S. investigator recently presented data which suggested to him that the heater probe was better than the laser. There is insufficient comparative data available to answer the critical question about the relative superiority of one endoscopic treatment modality as compared to another. Foreseeable technologic advances may make laser therapy easier and more effective.

Original languageEnglish (US)
Pages (from-to)52-55
Number of pages4
JournalEndoscopy
Volume18
Issue numberSUPPL. 2
StatePublished - 1986
Externally publishedYes

Fingerprint

Light Coagulation
Lasers
Hemorrhage
Laser Therapy
Gastrointestinal Diseases
Varicose Veins
United States Food and Drug Administration
Hemostasis
Ulcer
Randomized Controlled Trials
Research Personnel
Equipment and Supplies
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Laser photocoagulation for upper gastrointestinal bleeding : The American experience. / Fleischer, D.

In: Endoscopy, Vol. 18, No. SUPPL. 2, 1986, p. 52-55.

Research output: Contribution to journalArticle

Fleischer, D. / Laser photocoagulation for upper gastrointestinal bleeding : The American experience. In: Endoscopy. 1986 ; Vol. 18, No. SUPPL. 2. pp. 52-55.
@article{dad43ba39c3c4ebd9e7f47d9ff4db325,
title = "Laser photocoagulation for upper gastrointestinal bleeding: The American experience",
abstract = "Laser use in the United States for the treatment of gastrointestinal disease in general, and for upper GI bleeding in particular has grown exponentially. In 1979, only 3 American medical centers were using lasers for the therapy of UGI bleeding. Today, lasers are employed in more than 200 centers. Recently, the Food and Drug Administration, which regulates its use, has ruled that it is safe and effective, and therefore is no longer considered to be an investigational device. Most commonly it is used to treat discrete lesions such as ulcers, but it has been employed for other lesions, including varices. A recent American randomized controlled trial assessing its efficacy in acute esophageal variceal bleeding, found it to be effective for initial hemostasis; however, rebleeding was common. A key question is whether or not the laser is superior to other less costly and more portable modalities for treating acute UGI bleeding. One U.S. investigator recently presented data which suggested to him that the heater probe was better than the laser. There is insufficient comparative data available to answer the critical question about the relative superiority of one endoscopic treatment modality as compared to another. Foreseeable technologic advances may make laser therapy easier and more effective.",
author = "D. Fleischer",
year = "1986",
language = "English (US)",
volume = "18",
pages = "52--55",
journal = "Endoscopy",
issn = "0013-726X",
publisher = "Georg Thieme Verlag",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Laser photocoagulation for upper gastrointestinal bleeding

T2 - The American experience

AU - Fleischer, D.

PY - 1986

Y1 - 1986

N2 - Laser use in the United States for the treatment of gastrointestinal disease in general, and for upper GI bleeding in particular has grown exponentially. In 1979, only 3 American medical centers were using lasers for the therapy of UGI bleeding. Today, lasers are employed in more than 200 centers. Recently, the Food and Drug Administration, which regulates its use, has ruled that it is safe and effective, and therefore is no longer considered to be an investigational device. Most commonly it is used to treat discrete lesions such as ulcers, but it has been employed for other lesions, including varices. A recent American randomized controlled trial assessing its efficacy in acute esophageal variceal bleeding, found it to be effective for initial hemostasis; however, rebleeding was common. A key question is whether or not the laser is superior to other less costly and more portable modalities for treating acute UGI bleeding. One U.S. investigator recently presented data which suggested to him that the heater probe was better than the laser. There is insufficient comparative data available to answer the critical question about the relative superiority of one endoscopic treatment modality as compared to another. Foreseeable technologic advances may make laser therapy easier and more effective.

AB - Laser use in the United States for the treatment of gastrointestinal disease in general, and for upper GI bleeding in particular has grown exponentially. In 1979, only 3 American medical centers were using lasers for the therapy of UGI bleeding. Today, lasers are employed in more than 200 centers. Recently, the Food and Drug Administration, which regulates its use, has ruled that it is safe and effective, and therefore is no longer considered to be an investigational device. Most commonly it is used to treat discrete lesions such as ulcers, but it has been employed for other lesions, including varices. A recent American randomized controlled trial assessing its efficacy in acute esophageal variceal bleeding, found it to be effective for initial hemostasis; however, rebleeding was common. A key question is whether or not the laser is superior to other less costly and more portable modalities for treating acute UGI bleeding. One U.S. investigator recently presented data which suggested to him that the heater probe was better than the laser. There is insufficient comparative data available to answer the critical question about the relative superiority of one endoscopic treatment modality as compared to another. Foreseeable technologic advances may make laser therapy easier and more effective.

UR - http://www.scopus.com/inward/record.url?scp=0022499678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022499678&partnerID=8YFLogxK

M3 - Article

C2 - 3519196

AN - SCOPUS:0022499678

VL - 18

SP - 52

EP - 55

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - SUPPL. 2

ER -